From Vaccines to Therapeutics: The Need for Distinct mRNA-LNP Design Principles
Abstract
Therapeutic mRNA-LNPs require design principles distinct from vaccines. Optimizing ionizable lipids, modifying or replacing PEG-lipids, and applying rational molecular design can improve immune compatibility, safety, and repeated-dose efficacy. These strategies reduce toxicity, unintended immune activation, and accelerated blood clearance, unlocking the full therapeutic potential of mRNA-LNPs beyond the vaccine paradigm.
Fields of Study & Subjects
RNA Interference and Gene Delivery
RNA and protein synthesis mechanisms
RNA Research and Splicing
Publication details
- Journal / source
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Volume
- 69
- Issue
- 7
- Pages
- 7538–7540
- Publication date
- 23 February 2026
- Language
- EN